D'Haese Pierre-François, Ranjan Manish, Song Alexander, Haut Marc W, Carpenter Jeffrey, Dieb Gerard, Najib Umer, Wang Peng, Mehta Rashi I, Chazen J Levi, Hodder Sally, Claassen Daniel, Kaplitt Michael, Rezai Ali R
Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV, United States.
Department of Electrical Engineering and Computer Science, Vanderbilt University, Nashville, TN, United States.
Front Hum Neurosci. 2020 Oct 7;14:593672. doi: 10.3389/fnhum.2020.593672. eCollection 2020.
The blood-brain barrier (BBB) limits therapeutic delivery in Alzheimer's disease (AD) and other neurological disorders. Animal models have demonstrated safe BBB opening and reduction in β-amyloid plaque with focused ultrasound (FUS). We recently demonstrated the feasibility, safety, and reversibility of FUS-induced BBB opening in the hippocampus and entorhinal cortex in six participants with early AD. We now report the effect of BBB opening with FUS treatment on β-amyloid plaque. Six participants underwent F-Florbetaben PET scan at baseline and 1 week after the completion of the third FUS treatment (60 days interval). PET analysis comparing the hippocampus and entorhinal cortex in the treated and untreated hemispheres revealed a decrease in the ratio of F-Florbetaben ligand binding. The standard uptake value ratios (SUVr) reduction ranged from 2.7% to 10% with an average of 5.05% (±2.76) suggesting a decrease in β-amyloid plaque.
Proc Natl Acad Sci U S A. 2020-4-13
Front Cell Dev Biol. 2025-8-14
Alzheimers Dement. 2025-6
J Ultrasound Med. 2025-3
Biomimetics (Basel). 2024-10-20
Neural Regen Res. 2025-10-1
Proc Natl Acad Sci U S A. 2020-4-13
Alzheimers Dement (N Y). 2019-7-9
Eur J Nucl Med Mol Imaging. 2012-3-23
IEEE Trans Med Imaging. 2003-11
Zotero 插件
